Mouse Fibroblast Growth Factor 21 (FGF21) Protein

Este producto es parte de FGF21 - Fibroblast Growth Factor 21
Product Graph
234€ (10 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Mouse Fibroblast Growth Factor 21 (FGF21) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx167460
tested applications
WB, SDS-PAGE

Description

Fibroblast Growth Factor 21 Protein is a recombinant Mouse protein expressed in E. coli.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Fibroblast Growth Factor 21 (FGF21)
Host
E. coli
Origin
Mouse
Conjugation
Unconjugated
Observed MW
Molecular Weight: Calculated MW: 23.6 kDa  Observed MW (SDS-PAGE): 24 kDa
Concentration: Prior to lyophilization: 200 µg/ml
Sequence Fragment: Ala29-Ala209
Tag: N-terminal His tag
Expression
Recombinant
Purity
> 90%
Size 1
10 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
500 µg
Form
Lyophilized Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/ml. Do not vortex.
Tested Applications
WB, SDS-PAGE
Buffer
Prior to lyophilization: 100 mM NaHCO<sub>3</sub>, 500 mM NaCl, pH 8.3, containing 1 mM EDTA, 1 mM DTT, 0.01% Sarcosyl, 5% Trehalose and Proclin-300.
Availability
Shipped within 5-7 working days.
Storage
Store at 2-8 °C for up to one month. Store at -80 °C for up to one year. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q9JJN1
Gene ID
56636
Alias
FGF-21
Background
Protein FGF21
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

FGF21 is a metabolic hormone belonging to the fibroblast growth factor family, primarily produced in the liver under conditions of fasting, stress, and ketogenic diet consumption. It regulates glucose metabolism, lipid homeostasis, and energy expenditure by activating FGF receptors in conjunction with the co-receptor β-Klotho. FGF21 enhances insulin sensitivity, promotes lipolysis in adipose tissue, and stimulates ketogenesis in the liver, making it a critical regulator during energy deficits. It has also been linked to reducing body weight and mitigating non-alcoholic fatty liver disease (NAFLD). Therapeutically, FGF21 analogs are being explored for treating type 2 diabetes, obesity, and metabolic disorders. Dysregulation of FGF21 has been observed in insulin resistance and cardiovascular diseases.

Related Products

EB0147

Bovine FGF21 (Fibroblast growth factor 21) ELISA Kit

Ver Producto
EH0130

Human FGF21 (Fibroblast growth factor 21) ELISA Kit

Ver Producto
EM0254

Mouse Fgf21 (Fibroblast growth factor 21) ELISA Kit

Ver Producto